查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600563

CRISPR 技术市场：按产品、应用和最终用户划分 - 2025-2030 年全球预测

CRISPR Technology Market by Offering (Product, Services), Application (Agricultural, Biomedical, Industrial), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年CRISPR技术市值为32.5亿美元，预计到2024年将达到37.7亿美元，复合年增长率为16.52%，到2030年将达到94.9亿美元。

CRISPR 技术是基因编辑的突破性工具，透过精确修改 DNA，彻底改变了遗传学和生物技术领域。其应用范围广泛，包括用于治疗遗传疾病的基因编辑、透过修改作物基因组来实现农业进步以及用于研究目的的转基因模型的开发。对未满足的关键字的需求是由它们解决未满足的医疗需求、提高农业生产力和促进科学研究的潜力所驱动的。最终用途领域包括医疗保健、农业和生物技术产业，每个产业都利用该技术来增强产品供应和创新。

主要市场统计
基准年[2023] 32.5亿美元
预测年份 [2024] 37.7亿美元
预测年份 [2030] 94.9亿美元
复合年增长率（%） 16.52%

市场成长受到需要新治疗方法的遗传疾病日益流行、确保粮食安全的农业生物技术进步以及公共和私营实体对研发的大量投资的影响。将 CRISPR 的应用范围从治疗和农业扩展到生质燃料生产和环境管理等领域，可以创造潜在的商机。为了利用这些机会，公司应该专注于策略伙伴关係和协作研究，将人工智慧灵活地整合到基因组学中进行精确编辑，以及开发强大的基因治疗传递系统。

然而，市场面临挑战，包括伦理和安全问题、严格的法律规范以及与 CRISPR 专利相关的智慧财产权的复杂性。克服这些挑战需要相关人员的全面参与来解决道德问题，有效地引导监管途径，并建立强而有力的智慧财产权管理策略。还有一些成熟的创新和探索领域，例如提高 CRISPR 的特异性和效率、开发新的递送机制以及探索研究较少或罕见遗传疾病的治疗应用。整体而言，市场动态是动态的，对于那些由创新驱动、能够驾驭监管环境、在突破技术界限的同时有效解决道德问题的公司来说，存在着巨大的机会。

市场动态：揭示快速发展的 CRISPR 技术市场的关键市场洞察

供需的动态交互作用正在改变 CRISPR 技术市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对遗传疾病新疫苗和治疗方法的需求不断增长
    • 增加对生物技术和製药领域的私人和公共投资
  • 市场限制因素
    • 由于政府法规，高成本且复杂
  • 市场机会
    • CRISPR技术的进步与改进
    • 在农业领域使用 CRISPR 技术的可能性
  • 市场挑战
    • CRISPR 技术的技术挑战与伦理议题

波特五力：驾驭 CRISPR 技术市场的策略工具

波特五力框架是了解 CRISPR 技术市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 CRISPR 技术市场的外部影响

外部宏观环境因素在塑造 CRISPR 技术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解 CRISPR 技术市场的竞争格局

对 CRISPR 技术市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 CRISPR 技术市场供应商绩效评估

FPNV定位矩阵是评估CRISPR技术市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对遗传疾病新疫苗和治疗方法的需求增加
      • 增加对生物技术和製药领域的私人和公共投资
    • 抑制因素
      • 与政府监管相关的高成本和复杂性
    • 机会
      • CRISPR技术的进步与改进
      • CRISPR技术在农业领域的潜在应用
    • 任务
      • 与 CRISPR 技术相关的技术挑战和伦理问题
  • 市场区隔分析
    • 我们提供什么：由于研究活动的激增和产品的改进，CRISPR套件和试剂的使用不断增加。
    • 应用：扩大 CRISPR 技术在农业领域的应用
    • 最终用户：CRISPR技术在生技公司的潜在应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化
    • CRISPR 正成为生质能源生产的可行解决方案
    • 扩大 CRISPR 技术的专利版图

第六章 CRISPR 技术市场：透过提供

  • 产品
    • 酵素
    • 引导RNA
    • 试剂套件和试剂
  • 服务
    • 细胞株工程
    • gRNA 设计与载体构建
    • 筛检服务

第七章 CRISPR 技术市场：依应用分类

  • 农业
  • 生物医学
  • 产业

第 8 章 CRISPR 技术市场：按最终用户划分

  • 学术和政府研究机构
  • 生技公司
    • 农业企业
    • 製药公司

第九章 美洲CRISPR技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区CRISPR技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的CRISPR技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • RoslinCT 开发基于 CRISPR 的治疗方法
    • 第一种人类 CRISPR 药物取得进展
    • ERS Genomics Limited (ERS) 与 Syngene International 签署许可协议
    • Revvity (RVTY) 推出新服务以扩大编辑技术的使用范围
    • Pencil Biosciences 融资 560 万英镑，用于推进罕见疾病的基因编辑
    • 整合式 DNA Technologies 与 Aldevron 结成策略联盟，为细胞和基因治疗开发商提供关键 CRISPR 组件
    • Bedoukian Research Inc. 与 Inscripta 合作，可持续开发和生产天然成分。
    • Scribe 宣布合作加速基于 CRISPR 的体内基因药物的开发
    • Vertex 表示计划在 FDA 做出决定之前推出首个 Crispr 基因编辑疗法
    • Sherlock Biosciences 收购 Sense Biodetection
    • Intellia Therapeutics 宣布收购 Relight Therapeutics

公司名单

  • Agilent Technologies, Inc.
  • Applied StemCell, Inc.
  • Beam Therapeutics Inc.
  • Caribou Biosciences, Inc.
  • Cellectis SA
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • Editas Medicine, Inc.
  • ERS Genomics Limited
  • Function Oncology
  • GeneCopoeia, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group Ltd. by Revvity, Inc.
  • Inscripta, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group Ltd.
  • Mammoth Biosciences, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Prime Medicine, Inc.
  • Scribe Therapeutics
  • Sherlock Biosciences, Inc.
  • Synthego Corporation
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • ToolGen, Inc.
  • TriLink BioTechnologies by Maravai Intermediate Holdings, LLC
  • Twist Bioscience Corporation
  • Verve Therapeutics, Inc.
Product Code: MRR-B1685377A648

The CRISPR Technology Market was valued at USD 3.25 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 16.52%, to USD 9.49 billion by 2030.

CRISPR technology, a groundbreaking tool for gene editing, has revolutionized the fields of genetics and biotechnology by allowing precise modifications to DNA. Its scope encompasses a vast range of applications including therapeutic gene editing for genetic disorders, agricultural advancements through crop genome modification, and the development of genetically engineered models for research purposes. The necessity for CRISPR technology is driven by its potential to address unmet medical needs, improve agricultural productivity, and facilitate scientific research. End-use sectors include healthcare, agriculture, and biotechnology industries, each leveraging the technology to enhance product offerings and innovations.

KEY MARKET STATISTICS
Base Year [2023] USD 3.25 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 9.49 billion
CAGR (%) 16.52%

Market growth is influenced by the increasing prevalence of genetic disorders that necessitate novel therapeutic approaches, advancements in agricultural biotechnology to ensure food security, and substantial investments in R&D from both public and private entities. Potential opportunities lie in expanding CRISPR applications beyond therapeutics and agriculture into areas like biofuel production and environmental management. To capitalize on these opportunities, companies should focus on strategic partnerships and collaborations, agile integration of AI in genomics for precision editing, and development of robust delivery systems for gene therapies.

However, the market faces challenges such as ethical and safety concerns, stringent regulatory frameworks, and the complex nature of intellectual property rights pertaining to CRISPR patents. Overcoming these challenges requires comprehensive stakeholder engagement to address ethical issues, navigating regulatory pathways efficiently, and establishing strong IP management strategies. Areas of innovation and research ripe for exploration include enhancing CRISPR specificity and efficiency, developing novel delivery mechanisms, and exploring therapeutic applications in less-studied or rare genetic conditions. Overall, the CRISPR technology market is dynamic, driven by innovation, with substantial opportunities for businesses that can navigate the regulatory landscape and address ethical considerations effectively while pushing forward technological boundaries.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CRISPR Technology Market

The CRISPR Technology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need for new vaccines and treatments for genetic diseases
    • Increasing private and public investments in biotechnological and pharmaceutical sectors
  • Market Restraints
    • High cost and complexities involved in the government regulations
  • Market Opportunities
    • Advancements and improvements in CRISPR technology
    • Potential use of CRISPR technology in the agriculture sector
  • Market Challenges
    • Technical challenges and ethical concerns associated with CRISPR technology

Porter's Five Forces: A Strategic Tool for Navigating the CRISPR Technology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CRISPR Technology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CRISPR Technology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CRISPR Technology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CRISPR Technology Market

A detailed market share analysis in the CRISPR Technology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CRISPR Technology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CRISPR Technology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Technology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied StemCell, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., ERS Genomics Limited, Function Oncology, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Scribe Therapeutics, Sherlock Biosciences, Inc., Synthego Corporation, Takara Holdings Inc., Thermo Fisher Scientific Inc., ToolGen, Inc., TriLink BioTechnologies by Maravai Intermediate Holdings, LLC, Twist Bioscience Corporation, and Verve Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Product and Services. The Product is further studied across Enzymes, Guide RNA, and Kits & Reagents. The Services is further studied across Cell Line Engineering, gRNA Design & Vector Construction, and Screening Services.
  • Based on Application, market is studied across Agricultural, Biomedical, and Industrial.
  • Based on End User, market is studied across Academics & Government Research Institutes and Biotechnology Companies. The Biotechnology Companies is further studied across Agricultural Companies and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Georgia, Illinois, Kentucky, Michigan, Mississippi, New Jersey, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
      • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complexities involved in the government regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CRISPR technology
      • 5.1.3.2. Potential use of CRISPR technology in the agriculture sector
    • 5.1.4. Challenges
      • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR technology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Increasing use of CRISPR kits & reagents with the surging research activities and product improvements
    • 5.2.2. Application: Proliferating use of CRISPR technology in the agricultural sector
    • 5.2.3. End-User: Potential application of CRISPR technology in biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization
    • 5.5.1. CRISPR becoming a viable solution for bioenergy production
    • 5.5.2. Expanding patent landscape for CRISPR technology

6. CRISPR Technology Market, by Offering

  • 6.1. Introduction
  • 6.2. Product
    • 6.2.1. Enzymes
    • 6.2.2. Guide RNA
    • 6.2.3. Kits & Reagents
  • 6.3. Services
    • 6.3.1. Cell Line Engineering
    • 6.3.2. gRNA Design & Vector Construction
    • 6.3.3. Screening Services

7. CRISPR Technology Market, by Application

  • 7.1. Introduction
  • 7.2. Agricultural
  • 7.3. Biomedical
  • 7.4. Industrial

8. CRISPR Technology Market, by End User

  • 8.1. Introduction
  • 8.2. Academics & Government Research Institutes
  • 8.3. Biotechnology Companies
    • 8.3.1. Agricultural Companies
    • 8.3.2. Pharmaceutical Companies

9. Americas CRISPR Technology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific CRISPR Technology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa CRISPR Technology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. RoslinCT Manufacture CRISPR-Based Therapy
    • 12.3.2. First Human CRISPR Drug Moves Forward
    • 12.3.3. ERS Genomics Limited ('ERS') Completes Licensing Agreement With Syngene International
    • 12.3.4. Revvity's (RVTY) New Launch to Widen Access to Editing Technology
    • 12.3.5. Pencil Biosciences Raises GBP 5.6 Million to Advance Gene Editing for Rare Diseases
    • 12.3.6. Integrated DNA Technologies and Aldevron Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers
    • 12.3.7. Bedoukian Research Inc. Partners with Inscripta to Sustainably Develop and Manufacture Naturally Produced Ingredients
    • 12.3.8. Scribe Announces Collaboration to Accelerate In Vivo CRISPR-Based Genetic Medicines
    • 12.3.9. Vertex Teases Launch Plans for First Crispr Gene Editing Therapy Ahead of FDA Decision
    • 12.3.10. Sherlock Biosciences to Acquire Sense Biodetection
    • 12.3.11. Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Applied StemCell, Inc.
  • 3. Beam Therapeutics Inc.
  • 4. Caribou Biosciences, Inc.
  • 5. Cellectis S.A.
  • 6. CRISPR Therapeutics AG
  • 7. Danaher Corporation
  • 8. Editas Medicine, Inc.
  • 9. ERS Genomics Limited
  • 10. Function Oncology
  • 11. GeneCopoeia, Inc.
  • 12. GenScript Biotech Corporation
  • 13. Horizon Discovery Group Ltd. by Revvity, Inc.
  • 14. Inscripta, Inc.
  • 15. Intellia Therapeutics, Inc.
  • 16. Lonza Group Ltd.
  • 17. Mammoth Biosciences, Inc.
  • 18. Merck KGaA
  • 19. New England Biolabs, Inc.
  • 20. OriGene Technologies, Inc.
  • 21. Prime Medicine, Inc.
  • 22. Scribe Therapeutics
  • 23. Sherlock Biosciences, Inc.
  • 24. Synthego Corporation
  • 25. Takara Holdings Inc.
  • 26. Thermo Fisher Scientific Inc.
  • 27. ToolGen, Inc.
  • 28. TriLink BioTechnologies by Maravai Intermediate Holdings, LLC
  • 29. Twist Bioscience Corporation
  • 30. Verve Therapeutics, Inc.

LIST OF FIGURES

  • FIGURE 1. CRISPR TECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR TECHNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CRISPR TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CRISPR TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CRISPR TECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CRISPR TECHNOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GUIDE RNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY GRNA DESIGN & VECTOR CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY AGRICULTURAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CRISPR TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CRISPR TECHNOLOGY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 278. CRISPR TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 279. CRISPR TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023